Medicon Valley Alliance (MVA) has signed an important collaboration agreement with Japan Bioindustry Association (JBA).
Below you will find the latest news from MVA. You can also sign up to our newsletter MVA Update.
MVA Update is an electronic newsletter providing you with news about MVA and an overview of our events and other relevant events in Medicon Valley. You can also check out our calendar for more information about life science events in the region.
If you have any questions regarding our news section or media inquiries then please contact David Munis Zepernick, Head of Press on +45 2498 1668.
With a new collaboration agreement, Medicon Valley Alliance and Japan Bioindustry Association will aim to establish partnerships between the industry and universities. The agreement includes all aspects of research, development and production as well as commercialization. Read the press release (10.10.2012).
In the continuing effort to promote Medicon Valley abroad, Executive Vice President, Charlotte Ahlgren Moritz has written a cover story for the New York Health Forum magazine. Among other things, Charlotte highlights the unique interplay in biotech and life sciences
A cocktail of economic growth, a rapid shift to a more Western oriented lifestyle and an ageing population has made South Korea one of Asia’s fastest growing pharmaceutical markets.
According to LIF, the industry organization for pharmaceutical companies in Sweden, the number of clinical trials in Sweden have decreased by 48% since 2004. But Sweden has a competitive platform for clinical research and should be able to regain a
Companies in Medicon Valley are critically dependent on the presence of talent. But in order to attract talent we must improve a number of things including lower income tax, access to good international schools and willingness from all of us
Would you also like to build strong Life Science relations in the U.S, Japan or South Korea?
A cocktail of economic growth, a rapid shift to a more Western lifestyle and a growing population that is getting older has made South Korea one of Asia’s fastest growing pharmaceutical markets. The Korean medical market with 50 million people
IPR rules and issues in relation to the Korean market – is patenting different in Korea, compared to Europe and USA?